Insulet Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Insulet Corp 公司

Insulet Corporation 是一家医疗设备公司。该公司主要从事为胰岛素依赖型糖尿病患者开发、制造和销售其持续胰岛素输送系统。Omnipod 系统包括 Omnipod 5 自动胰岛素输送系统 (Omnipod 5)、Omnipod DASH 胰岛素管理系统、Omnipod 胰岛素管理系统和 Omnipod GO。该公司还为安进公司生产用于 Neulasta Onpro 套件的胶囊，该套件是安进公司 Neulasta 的输送系统。Omnipod 平台提供持续胰岛素输送，可提供胰岛素泵治疗的各种益处，而无需传统泵所需的外部管道。小巧、轻便、自粘式一次性无管 Omnipod 设备 (Pod) 可佩戴在多个位置，包括腹部、臀部、上臂后部、大腿上部或下背部，并通过小型柔性管将胰岛素输送到体内。Omnipod 5 包括嵌入在 Pod 中的 AID 算法。

公司简介

公司代码PODD

公司名称Insulet Corp

上市日期May 15, 2007

成立日期2000

CEOMs. Ashley Mcevoy

员工数量3900

证券类型Ordinary Share

年结日May 15

公司地址100 Nagog Park

城市ACTON

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编01720-3440

电话19786007000

网址https://www.omnipod.com

公司代码PODD

上市日期May 15, 2007

成立日期2000

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

4.46K

--

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

2.79K

--

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.12K

+53.26%

名称

名称/职务

职务

持股

持股变动

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

业务USD

名称

营收

占比

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

地区USD

名称

营收

占比

United States

1.55B

74.73%

All Other

523.40M

25.27%

业务

地区

业务USD

名称

营收

占比

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

持股股东

股东统计

占比

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

股东类型

股东统计

占比

Investment Advisor

55.61%

Investment Advisor/Hedge Fund

35.89%

Hedge Fund

3.60%

Research Firm

2.91%

Pension Fund

1.75%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.36%

Private Equity

0.33%

Individual Investor

0.28%

机构持股

更新时间: 1月20日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q1

1508

72.93M

103.85%

-4.38M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

953.02K

1.36%

-911.00

-0.10%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

Langar Global HealthTech ETF

6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

5.13%

Goldman Sachs Future Health Care Equity ETF

4.71%

Global X Telemedicine & Digital Health ETF

4.21%

Fidelity Digital Health ETF

3.91%

Congress SMid Growth ETF

2.6%

Harbor Health Care ETF

2.32%

iShares U.S. Medical Devices ETF

2.03%

First Trust Health Care Alphadex Fund

1.8%

iShares Health Innovation Active ETF

1.76%

Langar Global HealthTech ETF

占比6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比5.13%

Goldman Sachs Future Health Care Equity ETF

占比4.71%

Global X Telemedicine & Digital Health ETF

占比4.21%

Fidelity Digital Health ETF

占比3.91%

Congress SMid Growth ETF

占比2.6%

Harbor Health Care ETF

占比2.32%

iShares U.S. Medical Devices ETF

占比2.03%

First Trust Health Care Alphadex Fund

占比1.8%

iShares Health Innovation Active ETF

占比1.76%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Insulet Corp

252.150USD

Insulet Corp

252.150

概览

公司